Form 4: Herbalife Director Maria Otero Awarded 11,879 RSUs

Herbalife Ltd. director Maria Otero received a grant of 11,879 restricted stock units as part of the company's 2023 Stock Incentive Plan.

Summary

• Maria Otero, a Director at Herbalife Ltd., acquired 11,879 restricted stock units (RSUs) on May 8, 2026.
• The RSUs were granted at no cost ($0.00) under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan.
• Following this transaction, Maria Otero directly owns a total of 95,129 shares of common stock.
• The total ownership figure includes 3,200 shares that were inadvertently omitted from previous Form 4 filings.
• The newly granted RSUs are scheduled to vest 100% on April 15, 2027, contingent upon continued service on the Board of Directors.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine and neutral-to-positive administrative filing that confirms director alignment with shareholders, though the correction of previously omitted shares is a minor clerical negative.

Positives

• The grant aligns director interests with those of shareholders through equity-based compensation.
• The reporting person maintains a significant stake in the company with over 95,000 shares owned.
• The vesting period requires a commitment of service through April 2027, ensuring management stability.

Negatives

• The issuance of new shares or units represents a minor dilution of existing shareholder equity.
• A previous reporting error resulted in 3,200 shares being omitted from prior public disclosures.

Risks

• Vesting of the 11,879 RSUs is subject to the director's continued service through April 15, 2027; cessation of service would result in forfeiture.

Future Outlook

The director is expected to remain on the Board of Directors through at least April 15, 2027, to satisfy the vesting requirements of the equity grant.

Management Comments

• The RSUs will vest 100% on April 15, 2027, subject to continued service on the Issuer's Board of Directors through such date.

Industry Context

StockSavvy.ai notes that equity-based compensation for directors is a standard practice in the consumer goods and health supplement industry to ensure that board members' incentives are tied to long-term stock performance.

Comparison to Industry Standards

• The use of a one-year cliff vesting period for director RSUs is consistent with practices at other mid-cap and large-cap companies like Nu Skin Enterprises or Medifast.
• The total ownership level for a non-employee director is within the typical range for established global health and wellness firms.

Corporate Governance

Related Party Transactions

• The issuance of 11,879 RSUs to Maria Otero, a director of the company, constitutes a related party transaction under standard compensation agreements.

Stakeholder Impact

• Shareholders: Minor dilution from the potential issuance of 11,879 new shares upon vesting.
• Directors: Increased equity stake and incentive to maintain board service.

Next Steps

• Vesting of 11,879 RSUs on April 15, 2027.

Key Dates

Recommendation

This is a routine insider transaction involving a director grant which does not signal a change in company fundamentals or strategic direction.

Keywords

Herbalife Ltd., HLF, Insider Trading, Form 4, Restricted Stock Units, Maria Otero, Director Compensation, Equity Grant